Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Go back to Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure| SANUWAVE Health, Inc. (NASDAQ: SNWV) | Delayed: 4.10 +0.10 (2.50%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.00 | 52 Week High | $0.20 | |||
| Open | $4.05 | 52 Week Low | $0.03 | |||
| Day High | $4.13 | P/E | N/A | |||
| Day Low | $3.92 | EPS | $-0.50 | |||
| Volume | 42,656 | |||||

